Market Overview

IGC Announces "Drops of Clarity" Marketing Initiatives for Hyalolex™


India Globalization Capital, Inc. (NYSE:IGC) announces the
launch of its branding campaign and marketing outreach for Hyalolex™, an
oral cannabinoid-based supplement for the treatment of symptoms
associated with Alzheimer's.

"In fiscal 2018, the Company's focus was to develop and lay the
foundation to commercialize cannabinoid based alternative therapies for
indications such as Alzheimer's disease, Parkinson's disease and pain.
According to the Alzheimer's Association, 'Alzheimer's is a brain
disease that causes a slow decline in memory, thinking and reasoning
skills'. The name Hyalolex™ is derived from the Greek prefix hyalo
meaning glass-like, clear, transparent. Our marketing and branding
campaign, therefore, is entitled ‘Drops of Clarity'.

This initiative will commence in several states where we will highlight
the potential benefits of Hyalolex™ as a supplement to authorized
cannabis physicians as well as to caregivers and patients via both a
digital format and through grassroots outreach. We expect to utilize
this methodology, in conjunction with licensing arrangements with
manufacturers, to expand our reach into multiple U.S. markets and
Canada. Education and product differentiation are key components for
‘Drops of Clarity'," said Ram Mukunda, CEO.

About Alzheimer's Disease

Alzheimer's disease (AD) is a form of dementia. It is known as America's
most expensive disease, with an estimated cost to the U.S. economy of
$236 billion. AD currently affects more than 5.3 million Americans and
over 65% of AD patients are women. Over the next 20 years, the number of
those afflicted with the disease is expected to double. The forecast is
staggering, considering that to date, no effective cure has been found.

About IGC

IGC has two lines of business, a legacy infrastructure business and a
cannabis pharmaceutical business that has developed a lead product for
treating Alzheimer's patients. The Company recently announced that it is
working on using blockchain to address issues specific to the cannabis
industry that address transactional difficulties, product labeling,
product identification assurance (PIA), and product origin assurance
(POA). The company is based in Maryland, USA.

Our website:
Twitter @IGCIR

Forward-looking Statements:

Please see forward looking statements as discussed in detail in IGC's
Form 10K for fiscal year ended March 31, 2018, and in other reports
filed with the U.S. Securities and Exchange Commission.

View Comments and Join the Discussion!